Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

NCT01314027 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped low recruitment

Conditions

Pancreatic Cancer

Interventions

DRUG: Neoadjuvant Chemotherapy with gemcitabine/oxaliplatin
DRUG: adjuvant chemotherapy with gemcitabine

Sponsor

University of Zurich